Oxacillin sodium description: Difference between revisions
No edit summary |
|||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Oxacillin sodium}} | {{Oxacillin sodium}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{MM}} | ||
==Description== | ==Description== | ||
Oxacillin for Injection, USP is a semisynthetic penicillin antibiotic derived from 6-amino-penicillanic acid. It is the sodium salt in a parenteral dosage form. Each vial of Oxacillin for Injection, USP contains oxacillin sodium monohydrate equivalent to 1 gram or 2 grams of oxacillin. The sodium content is 57.30 mg [2.5 mEq] per gram oxacillin. The product is buffered with 20 mg sterile disodium hydrogen phosphate per gram oxacillin. | Oxacillin for Injection, USP is a semisynthetic penicillin antibiotic derived from 6-amino-penicillanic acid. It is the sodium salt in a parenteral dosage form. Each vial of Oxacillin for Injection, USP contains oxacillin sodium monohydrate equivalent to 1 gram or 2 grams of oxacillin. The sodium content is 57.30 mg [2.5 mEq] per gram oxacillin. The product is buffered with 20 mg sterile disodium hydrogen phosphate per gram oxacillin. | ||
Oxacillin for Injection, USP is a sterile,white to off-white powder supplied in vials. | Oxacillin for Injection, USP is a sterile, white to off-white powder supplied in vials. | ||
Oxacillin sodium, C19H18N3NaO5S | Oxacillin sodium, C19H18N3NaO5S H2O molecular weight 441.43, is designated as 4-Thia-1-azabicyclo [3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-6-[[(5-methyl-3-phenyl-4-isoxazolyl) carbonyl] amino]-7-oxo-, monosodium salt, monohydrate, [2S(2α,5α,6β)] and has the following structural formula:<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = OXACILLIN (OXACILLIN SODIUM) INJECTION, POWDER, FOR SOLUTION [AUROMEDICS PHARMA LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=81e90279-9889-47bd-974b-334c181f295c#nlm34089-3 | publisher = | date = | accessdate}}</ref> | ||
{| | {| | ||
Line 15: | Line 13: | ||
| [[File:Oxacillin.jpg|300px|thumb]] | | [[File:Oxacillin.jpg|300px|thumb]] | ||
|} | |} | ||
==References== | ==References== |
Latest revision as of 17:38, 26 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Description
Oxacillin for Injection, USP is a semisynthetic penicillin antibiotic derived from 6-amino-penicillanic acid. It is the sodium salt in a parenteral dosage form. Each vial of Oxacillin for Injection, USP contains oxacillin sodium monohydrate equivalent to 1 gram or 2 grams of oxacillin. The sodium content is 57.30 mg [2.5 mEq] per gram oxacillin. The product is buffered with 20 mg sterile disodium hydrogen phosphate per gram oxacillin.
Oxacillin for Injection, USP is a sterile, white to off-white powder supplied in vials.
Oxacillin sodium, C19H18N3NaO5S H2O molecular weight 441.43, is designated as 4-Thia-1-azabicyclo [3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-6-[[(5-methyl-3-phenyl-4-isoxazolyl) carbonyl] amino]-7-oxo-, monosodium salt, monohydrate, [2S(2α,5α,6β)] and has the following structural formula:[1]
References
- ↑ "OXACILLIN (OXACILLIN SODIUM) INJECTION, POWDER, FOR SOLUTION [AUROMEDICS PHARMA LLC]". Text " accessdate" ignored (help)
Adapted from the FDA Package Insert.